Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke

Documenti analoghi

• Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke
  di: Alicia Sierra‐Gómez, et al.
  Pubblicazione: (2024)
• Acute ischaemic stroke in active cancer versus non‐cancer patients: stroke characteristics, mechanisms and clinical outcomes
  di: Gianluca Costamagna, et al.
  Pubblicazione: (2024)
• Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke
  di: Jinghan Xu, et al.
  Pubblicazione: (2024)
• Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke
  di: Muath Alobaida, et al.
  Pubblicazione: (2024)
• Trajectories of physical activity after ischaemic stroke: Exploring prediction of change
  di: Andreas Gammelgaard Damsbo, et al.
  Pubblicazione: (2024)